Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing

被引:1
|
作者
Feng, Hongxuan [1 ]
Li, Qinshan [1 ]
Margolis, Russell L. [1 ,2 ]
Li, Pan P. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, 600 N Wolfe St, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
D O I
10.1016/j.scr.2021.102346
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Spinocerebellar ataxia type 12 (SCA12) is caused by a CAG expansion mutation in PPP2R2B, a gene encoding a brain-specific regulatory unit of protein phosphatase 2A (PP2A); while normal alleles carry 4 to 31 triplets, the disease alleles carry 43 to 78 triplets. Here, by CRISPR/Cas9 genome editing, we have generated a human homozygous SCA12 iPSC line with 69 and 72 triplets for each allele. The homozygous SCA12 iPSCs have normal karyotype, express pluripotency markers and are able to differentiate into the three germ layers.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Generation of human induced pluripotent stem cell line UNIGEi003-A from skin fibroblasts of an apparently healthy male donor
    Cosset, Erika
    Vannary, Tieng
    Sloan-Bena, Frederique
    Gimelli, Stefania
    Gerstel, Eric
    Krause, Karl-Heinz
    Marteyn, Antoine
    STEM CELL RESEARCH, 2020, 48
  • [42] Generation of 3 spinocerebellar ataxia type 1 (SCA1) patient-derived induced pluripotent stem cell lines LUMCi002-A, B, and C and 2 unaffected sibling control induced pluripotent stem cell lines LUMCi003-A and B
    Buijsen, Ronald A. M.
    Gardiner, Sarah L.
    Bouma, Marga J.
    van der Graaf, Linda M.
    Boogaard, Merel W.
    Pepers, Barry A.
    Eussen, Bert
    de Klein, Annelies
    Freund, Christian
    van Roon-Mom, Willeke M. C.
    STEM CELL RESEARCH, 2018, 29 : 125 - 128
  • [43] Generation of a human induced pluripotent stem cell line (INNDSUi003-A) derived from patient with Becker muscular dystrophy (BMD)
    Ji, Xinbo
    Wang, Yu
    Sun, Ping
    Wang, Dongdong
    Sun, Xiaohan
    Zhang, Rui
    Xu, Jingwen
    Li, Wei
    Liu, Fuchen
    Yan, Chuanzhu
    STEM CELL RESEARCH, 2022, 62
  • [44] TRANSCRIPTIONAL PROFILING OF NEURONAL CULTURES DERIVED FROM SPINOCEREBELLAR ATAXIA TYPE 3 INDUCED PLURIPOTENT STEM CELL LINES
    Matos Santana, M.
    Adao, D.
    de Luca, P.
    Martins, R.
    Fernandes, A.
    Pinto, M.
    Perdigao, P.
    Lopes, S. M.
    Pereira de Almeida, L.
    CYTOTHERAPY, 2024, 26 (06) : E32 - E32
  • [45] Generation of an induced pluripotent stem cell line from a type 1 neurofibromatosis patient with NF1 mutation
    Xin, Hongmei
    Li, Yixiao
    Zhang, Kaihui
    Ji, Aihua
    Fan, Meili
    STEM CELL RESEARCH, 2024, 81
  • [46] Generation of human induced pluripotent stem cells from individuals with a homozygous CCR5Δ32 mutation
    Chen, Guibin
    Jin, Hui
    Yu, Zhen
    Liu, Yangtengyu
    Li, Zhongwen
    Navarengom, Keron
    Schwartzbeck, Robin
    Dmitrieva, Natalia
    Cudrici, Cornelia
    Ferrante, Elisa A.
    Biesecker, Leslie G.
    Yang, Dan
    Boehm, Manfred
    STEM CELL RESEARCH, 2019, 38
  • [47] Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9
    Ratnavadivel, Sandra
    Dammeier, Joline
    Gaertner, Anna
    de Toledo, Marcelo A. Szymanski
    Zenke, Martin
    Gummert, Jan
    Rasmussen, Torsten Bloch
    Klinke, Nora
    Juergens, Kai
    Meyer, Heiko
    Paululat, Achim
    Milting, Hendrik
    STEM CELL RESEARCH, 2024, 76
  • [48] Generation of human induced pluripotent stem cell lines (LUMCi051-A,B and LUMCi052-A,B,C) of two patients with Spinocerebellar ataxia type 7
    Bouwman, Linde F.
    Joosen, Milou E. M.
    Buijsen, Ronald A. M.
    van der Graaf, Linda M.
    Pepers, Barry A.
    Voesenek, Bas J. B.
    Brosens, Erwin
    van de Warrenburg, Bart P. C.
    van Roon-Mom, Willeke M. C.
    STEM CELL RESEARCH, 2024, 78
  • [49] Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing
    Bu, Qian
    Zhang, Huaqin
    Liu, Qian
    Dai, Yanping
    Wei, Qian
    Xue, Aiqin
    Huang, Yan
    Zhong, Kai
    Huang, Yina
    Gao, Hong
    Cen, Xiaobo
    STEM CELL RESEARCH, 2020, 49
  • [50] Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies
    Yamashita, Tomoki
    Takayama, Kazuo
    Hori, Mika
    Harada-Shiba, Mariko
    Mizuguchi, Hiroyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (03) : 312 - 318